Cisplatin upregulates MSH2 expression by reducing miR-21 to inhibit A549 cell growth
about
MicroRNAs in the DNA Damage/Repair Network and CancerResistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.DNA damage response in cisplatin-induced nephrotoxicity.miR-21 promotes human nucleus pulposus cell proliferation through PTEN/AKT signaling.MicroRNA-21: a therapeutic target for reversing drug resistance in cancer.Targeting the microRNA-regulating DNA damage/repair pathways in cancer.The roles and perspectives of microRNAs as biomarkers for intervertebral disc degeneration.Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.MicroRNA-21 antisense oligonucleotide improves the sensitivity of A375 human melanoma cell to Cisplatin: An in vitro study.
P2860
Q21284509-C902BDEC-418A-4550-A8C9-521A3464719FQ33850064-3C182DAE-8444-4841-B96E-A94FFA345903Q36525449-FCCF6B94-1112-4137-AD4E-55E80459A49FQ37684015-A7B24D89-21FC-4E4C-B352-8F4660AAE2FEQ38122420-34772A29-A1DD-4007-ABFA-C994E9866708Q38246220-6E51D908-80D2-4C31-B2B5-8629BAD590D1Q39159852-64D8E31A-DC75-4F10-8E23-827C2AC41575Q47107773-9F00AA7C-C5E1-4816-8D31-CA6B5E02E0E6Q48146192-FA04BDB3-9C9D-43E9-9A5B-85662562712F
P2860
Cisplatin upregulates MSH2 expression by reducing miR-21 to inhibit A549 cell growth
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cisplatin upregulates MSH2 expression by reducing miR-21 to inhibit A549 cell growth
@en
type
label
Cisplatin upregulates MSH2 expression by reducing miR-21 to inhibit A549 cell growth
@en
prefLabel
Cisplatin upregulates MSH2 expression by reducing miR-21 to inhibit A549 cell growth
@en
P2093
P2860
P1476
Cisplatin upregulates MSH2 expression by reducing miR-21 to inhibit A549 cell growth
@en
P2093
Jia-Xuan Xin
Ping-Yu Wang
Qing-Yin Zheng
Shu-Yang Xie
Yan-Xia Zhang
You-Jie Li
P2860
P304
P356
10.1016/J.BIOPHA.2012.11.008
P577
2012-12-28T00:00:00Z